Skip to content

Interest in Factor XIII at AACR 2025

FACTOR XIIIA Update – Benchmark Antibodies

Hello Scientist,

Another busy AACR is in the books! We followed several interesting topics this year, but notably Factor XIIIa was one of the most frequently studied targets of interest.

Benchmark Antibodies has now expanded the premium IVD for R&D reagent catalogue to include diagnostic grade FACTOR XIIIA antibody clones:

  • – Mouse Anti-Factor XIIIa monoclonal antibody (ZM84) 6181

    • IVD for R&D precision antibodies are developed by pathologists to provide diagnostic grade target specificity and reproducibility validated reagents for your IHC research applications.

    Why use IVD reagents for research applications? The IVD for R&D clones are invaluable for eliminating the guess-work and inconsistencies of research grade reagents.

    IVD for R&D Mouse Anti-Factor XIIIa monoclonal antibody (ZM84) 6181
  • RELIABLE QUALITY
    – ISO/GMP monoclonal manufacturing and IVD validation guarantees batch consistency and reproducibility
  • ECONOMICAL
    – IVD workflow reagents ensure uninterrupted supply and lowest market prices
  • EASY-TO-USE
    – Well characterized protocols with real-time North American technical support and order fulfillment
    		•  Human neuroblastoma.
    Human neuroblastoma stained with anti-Factor XIIIa antibody using peroxidase-conjugate and DAB chromogen. Note the cytoplasmic staining of fibroblasts and macrophages.

    TECHNICAL RESOURCES:
  • Immunohistochemistry Protocol
  • Anti-Factor XIIIa mouse monoclonal antibody (ZM84) 6181
    		•

    Please visit us and feel free to contact us if you have any questions or if we can provide you with additional information.
    We look forward to hearing from you!

    Best regards,
    Team Benchmark